Y-K. Shi

CSR1 induces cell death through inactivation of CPSF3

Z-H Zhu, Yang Yu, Y-K. Shi et al. · Oncogene · 2008 · 56 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +9

Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7

Y-K. Shi, Yanping Yu, George C. Tseng et al. · Cancer Gene Therapy · 2010 · 20 citations

Medicine, Molecular Biology, Oncology +16

LBA48 DUBLIN-3 (BPI-2358-103): A global phase (Ph) III trial with the plinabulin/docetaxel (Plin/Doc) combination vs. Doc in 2nd/3rd Line NSCLC patients (pts) with EGFR-wild type (wt) progressing on a prior platinum-based regimen

Baohui Han, Y-K. Shi, Trevor Feinstein et al. · Annals of Oncology · 2021 · 11 citations · Full text

Medicine, Oncology, Pharmacology +8